PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Newly appointed Secretary of Transportation Sean Duffy said during a press conference that both aircrafts involved in a deadly midair collision near Reagan Washington National Airport were both in ...

The chances of a Reserve Bank interest rate cut in February have improved significantly as price rises ease. So what's behind the inflation pull-back?

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...

The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group ...

Given the rapid growth of online medical consultations and pharmaceutical e-commerce, the guidelines, for the first time, incorporate measures to address monopolistic practices in online medicine ...

Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for ...

On Friday, shares of Zealand Pharma A/S (NASDAQ:ZEAL:DC) (NASDAQ: ZEAL) maintained their Overweight rating, as reiterated by Cantor Fitzgerald. The firm expressed a strong positive outlook on the ...

Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller, Connecticut ...

Dr. Gehchan brings 20 years of U.S. and international experience across multiple therapeutic areas, including immunology, as both an accomplished pharmaceutical executive and a physician to this newly ...

The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a major ...